Chimerix, Inc. (CMRX)
NASDAQ: CMRX · Real-Time Price · USD
8.47
0.00 (-0.02%)
Mar 14, 2025, 12:35 PM EDT - Market open
Chimerix Employees
Chimerix had 72 employees as of December 31, 2023. The number of employees decreased by 17 or -19.10% compared to the previous year.
Employees
72
Change (1Y)
-17
Growth (1Y)
-19.10%
Revenue / Employee
$2,208
Profits / Employee
-$1,161,028
Market Cap
761.61M
Employees Chart
CMRX News
- 3 days ago - CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRX - Business Wire
- 6 days ago - Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders - PRNewsWire
- 9 days ago - Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline - Benzinga
- 9 days ago - Jazz Pharmaceuticals to buy Chimerix for $935 million - Reuters
- 9 days ago - Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio - GlobeNewsWire
- 21 days ago - Chimerix: Potential 'First' In Targeting Recurrent High-Grade Glioma Patients - Seeking Alpha
- 6 weeks ago - Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium - GlobeNewsWire